Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
Spell
Derrick W
DW
Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA. dspell@lsuhsc.edu
Estephan
Fadi F
FF
Lin
James T
JT
Jones
Dennie V
DV
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000077143:Docetaxel; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel